“One-Stop Shop” for all of your clinical trial needs

Pharma Clinical is an independent Contract Research Organization (CRO) offering a full range of clinical development services, as well as Due Diligence services for funds and investors.

why pharma clinical

At Pharma Clinical we have a fundamental belief in resourceful teamwork for achieving successful clinical trials. Working closely with our clients on their most important projects, we treat all clinical trials as our own, and are fully motivated to succeed.

flexible services

unique financing model

end-to-end services

long-term mentoring

vision To provide top quality, global-level study management services to Israeli biotech innovators, turning their INNOVATION into REALITY.

mission To create a new platform specializing in clinical development support for medical innovators, provided by passionate and value-driven professionals.

30 years

of experience

40 Employees

300
Studies

20,000

Patients

Pharma Clinical is a formal partner of the ACROSS Global Alliance of Clinical Research Organizations

Andreas Kuhl

Director of European Operations

"The Pharma Clinical team is such a great partner. We definitely need to clone you! I’ve never worked with a clinical partner with more engagement, enthusiasm, reliability, and professionalism. Pharma Clinical lifts the CRA business to a new level."

Zuzana Jirakova

Chief Medical Officer

"It feels more like working in a team rather than working with an external vendor."

Andrea Parker

Senior Director, Clinical Operations

"I highly recommend Pharma Clinical to anyone seeking a top-tier Project Manager who consistently goes above and beyond to achieve success."

Anne Rubin

President, Co-Founder

"Pharma Clinical expertly guided us through the Israeli regulatory process to start a Phase 1 study for a very novel therapeutic in Israel. Their team has continued to be a valued partner with strong technical acumen for science, operations, and monitoring as we have enrolled this study. Their humble and collaborative approach is appreciated by the main clinical site and global partners."